View More View Less
  • 1 Semmelweis University 3rd Department of Internal Medicine Kútvölgyi út 4 1125 Budapest Hungary
  • 2 Semmelweis University Department of Pathophysiology Budapest Hungary
Restricted access

A 62-year-old male who had Gaucher’s and Parkinson’s disease coexistently, developed iron accumulation in the bone marrow interstitially and in the Gaucher cells themselves. As it is shown here, this kind of iron overload was not associated with any of the HFE gene mutations in this single case. Further studies are required to focus on the pathomechanism of local iron overload in the Gaucher cells themselves and the Gaucher disease separately and in combination with Parkinson’s disease. Recommendations on iron chelating therapy and copper supplementation will be also considered.

  • Lee, R. E., Balcerzak, S. P., Westerman, M. P.: Gaucher’s disease. Am. J. Med., 1967, 42 , 891–898.

    Westerman M. P. , 'Gaucher’s disease ' (1967 ) 42 Am. J. Med. : 891 -898.

  • Knutson, M. D., Oukka, M., Koss, L. M., Aydemir, F. et al.: Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. PNAS, 2005, 102 , 1324–1328.

    Aydemir F. , 'Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin ' (2005 ) 102 PNAS : 1324 -1328.

    • Search Google Scholar
  • Chung, J., Halle, D. J., Wessling-Resnick, M.: Copper-induced ferroportin-1 expression in J774 macrophages is associated with increased iron efflux. PNAS, 2004, 101 , 2700–2705.

    Wessling-Resnick M. , 'Copper-induced ferroportin-1 expression in J774 macrophages is associated with increased iron efflux ' (2004 ) 101 PNAS : 2700 -2705.

    • Search Google Scholar
  • Glasser, L., Legolvan, M., Horwitz, H. M.: Florid histiocytic hemophagocytosis following therapy with long acting G-CSF (pegfilgrastim). Am. J. Hematol, 2007 (in press).

  • Várkonyi, J., Simon, Z. S., Soós, K., Poros, A.: Gaucher disease type I complicated with Parkinson’s syndrome. Haematologia, 2002, 32 , 271–275.

    Poros A. , 'Gaucher disease type I complicated with Parkinson’s syndrome ' (2002 ) 32 Haematologia : 271 -275.

    • Search Google Scholar
  • Hayhoe, F. G. J., Quaglino, G.: Haematological Cytochemistry. Churchill Livingstone, 1980. ISBN 0-443-01974-6.

    Quaglino G. , '', in Haematological Cytochemistry , (1980 ) -.

  • Feder, J. N., Gnirke, A., Thomas, W. et al.: A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet., 1996, 13 , 399–408.

    Thomas W. , 'A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis ' (1996 ) 13 Nat. Genet. : 399 -408.

    • Search Google Scholar
  • Aharon-Peretz, J., Rosembaum, H., Gershoni-Baruch, R.: Mutations in the glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews. NEJM, 2004, 351 , 1972–1977.

    Gershoni-Baruch R. , 'Mutations in the glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews ' (2004 ) 351 NEJM : 1972 -1977.

    • Search Google Scholar
  • Tayebi, N., Walker, J., Stubblefield, B., Orvisky, E., LaMarca, M. E., Wong, K., Rosembaum, H., Schiffmann, R., Bembi, B., Sidransky, E.: Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol. Genet. Metab., 2003, 79 , 104–109.

    Sidransky E. , 'Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? ' (2003 ) 79 Mol. Genet. Metab. : 104 -109.

    • Search Google Scholar
  • Berg, D., Hochstrasser, H.: Iron metabolism in Parkinsonian syndromes. Movement Disorders, 2006, 21 , 1299–1310.

    Hochstrasser H. , 'Iron metabolism in Parkinsonian syndromes ' (2006 ) 21 Movement Disorders : 1299 -1310.

    • Search Google Scholar
  • Várkonyi, J., Tarkovács, G., Karádi, I., Andrikovics, H., Varga, F., Varga, F., Demeter, J., Tordai, A.: High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: The Budapest study on 50 patients. Acta Haematol., 2003, 109 , 64–67.

    Tordai A. , 'High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: The Budapest study on 50 patients ' (2003 ) 109 Acta Haematol. : 64 -67.

    • Search Google Scholar
  • Huff, J. D., Keung, Y. K., Thakuri, M., Beaty, M. W., Hurd, D. D., Owen, J., Molnár, I.: Copper deficiency causes reversible myelodysplasia. Am. J. Hematol., 2007, 82 , 625–630.

    Molnár I. , 'Copper deficiency causes reversible myelodysplasia ' (2007 ) 82 Am. J. Hematol. : 625 -630.

    • Search Google Scholar
  • Barton, J. C.: Optimal management strategies for chronic iron overload. Drugs, 2007, 67 , 685–700.

    Barton J. C. , 'Optimal management strategies for chronic iron overload ' (2007 ) 67 Drugs : 685 -700.

    • Search Google Scholar
  • Akbas, N., Hochstrasser, H., Deplazes, J., Tomiuk, J., Bauer, P., Walter, U. et al.: Screening for mutations of the HFE gene in Parkinson’s disease patients with hyperechogenicity of the substantia nigra. Neurosci. Lett., 2006, 407 , 16–19.

    Walter U. , 'Screening for mutations of the HFE gene in Parkinson’s disease patients with hyperechogenicity of the substantia nigra ' (2006 ) 407 Neurosci. Lett. : 16 -19.

    • Search Google Scholar